Koers Shenzhen Hepalink Pharmaceutical Group Co., Ltd.
Aandelen
002399
CNE100000P02
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
8,95 CNY | +1,02% | +0,90% | -23,70% |
Omzet 2024 * | 5,63 mld. 777 mln. 724 mln. | Omzet 2025 * | 6,47 mld. 893 mln. 833 mln. | Marktkapitalisatie | 11,77 mld. 1,62 mld. 1,51 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 649 mln. 89,55 mln. 83,51 mln. | Nettowinst (verlies) 2025 * | 739 mln. 102 mln. 95,09 mln. | EV/omzet 2024 * | 1,97 x |
Nettoliquiditeiten 2024 * | 67,8 mln. 9,36 mln. 8,72 mln. | Nettoschuld 2025 * | 4,03 mld. 556 mln. 519 mln. | EV/omzet 2025 * | 2,57 x |
K/w-verhouding 2024 * |
20,3
x | K/w-verhouding 2025 * |
17,9
x | Werknemers | 2.080 |
Dividendrendement 2024 * |
0,56% | Dividendrendement 2025 * |
0,67% | Vrij verhandelbaar | 17,01% |
1 dag | +1,02% | ||
1 week | +0,90% | ||
Lopende maand | +7,19% | ||
1 maand | +1,13% | ||
3 maanden | -2,51% | ||
6 maanden | -23,04% | ||
Lopend jaar | -23,70% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Yu Shan
FOU | Founder | 64 | 21-04-98 |
Tan Li
FOU | Founder | 60 | 21-04-98 |
Juan Chen
DFI | Director of Finance/CFO | 49 | 21-08-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Tan Li
FOU | Founder | 60 | 21-04-98 |
Peng Huang
BRD | Director/Board Member | 75 | 22-05-23 |
Li Li
FOU | Founder | 60 | 21-04-98 |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-04-24 | 8,95 | +1,02% | 2 884 960 |
23-04-24 | 8,86 | -1,12% | 3 106 423 |
22-04-24 | 8,96 | -0,33% | 4 246 516 |
19-04-24 | 8,99 | -0,77% | 4 707 580 |
18-04-24 | 9,06 | +2,14% | 7 194 520 |
slotkoers Shenzhen S.E., 24 april 2024
Meer koersenHerzieningen van WPA
Kwartaalomzet - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
-23,70% | 1,62 mld. | |
+20,70% | 42,78 mld. | |
+18,59% | 22,25 mld. | |
+14,67% | 14,39 mld. | |
+12,83% | 13,55 mld. | |
+38,02% | 11,27 mld. | |
-9,80% | 6,95 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+6,29% | 5,01 mld. |